Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07465471) titled 'Carvedilol and Midodrine Versus Carvedilol Alone in Preventing Early Rebleed in Patients With Cirrhosis' on March 6.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).

Primary Sponsor: Institute of Liver and Biliary Sciences, India

Condition: Liver Cirrhosis

Intervention: Drug: Carvedilol

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: March 1, 2026

Target Sample Size: 210

Countries of Recruitment: India

To know more, visit https://clinicaltrials.gov/study/NCT07465...